Replies to post #261161 on Avid Bioservices Inc (CDMO)

[jq1234]

>> 12.1+4.8=16.9 months POTENTIAL for Bavituximab, So 14 MONTHS expectation for the Bavituximab arm in SUNRISE is a quite safe expectation.


Yea right, just like the "safe" assumption about 1st look-in:

138 CTRL ARM events
16 BAVI ARM events

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120462194

Called it BS then, call it BS now!

[jbainseky]

moreover, you DON'T KNOW what margin PPHM was talking about. Margin could be in the number of patients necessary to achieve the desired statistical results. It could be in the estimates on the sickness of the patients. It could be on the anticipated allocations across trial sites. It could be in many different areas, YOU DON'T KNOW what the trial design was.

FFTT

JBAIN